Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Pain and Headache Reports
Published in: Current Pain and Headache Reports 3/2013

01-03-2013 | Anesthetic Techniques in Pain Management (K Williams, Section Editor)

Peripheral Nerve Stimulation for the Treatment of Primary Headache

Authors: Pyungbok Lee, Billy K. Huh

Published in: Current Pain and Headache Reports | Issue 3/2013

Login to get access

Abstract

A headache is a common neurological disorder, and large numbers of patients suffer from intractable headaches including migraine, tension headache and cluster headache, etc., with no clear therapeutic options. Despite the advances made in the treatment of headaches over the last few decades, subsets of patients either do not achieve adequate pain relief or cannot tolerate the side effects of typical migraine medications. An electrical stimulation of the peripheral nerves via an implantable pulse generator appears to be good alternative option for patients with treatment-refractory headaches. A number of clinical trials show considerable evidence supporting the use of peripheral nerve stimulator (PNS) for headaches not responding to conservative therapies. However, the mechanism by which PNS improves headaches or predicts who will benefit from PNS remains uncertain. The decision to use PNS should be individualized based on patient suffering and disability. Hence, further work is imperative. Here, we discuss the mechanism, indication, efficacy, implant technique, and complications of PNS.
Literature
1.
Menken M, Munsat TL, Toole JF. The global burden of disease study-implications for neurology. Arch Neurol. 2000;57:418–20.PubMedCrossRef
2.
Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193–210.PubMedCrossRef
3.
Shelden CH. Depolarization in the treatment of trigeminal neuralgia. Evaluation of compression and electrical methods; clinical concept of neurophysiological mechanism. In: Knighton RS, Dumke PR, editors. Pain. Boston: Little, Brown, 1966:373–86.
4.
5.
Weiner RL, Reed KL. Peripheral neurostimulation for control of intractable occipital neuralgia. Neuromodulation. 1999;2:217–21.PubMedCrossRef
6.
•• Silberstein S, Dodick D, Saper S et al. Safety and Efficacy of Peripheral Nerve Stimulation of the Occipital Nerves for the Management of Chronic Migraine: Results from a Randomized, Prospective, Multicenter, Double-blinded, Controlled Study. Cephalgia. 2012;32(16):1165–79. This article is the first large scale study of PNS of the occipital nerves in migraine patients that showed significant reductions in pain, headache days, and migraine-related disability.
7.
8.
Matharu MS, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004;127(Pt 1):220–30.PubMedCrossRef
9.
Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain. 2002;125:1496–509.PubMedCrossRef
10.
Bartsch T, Goadsby PJ. Increased responses in trigeminocervical nociceptive neurones to cervical input after stimulation of the dura mater. Brain. 2003;126:1801–13.PubMedCrossRef
11.
Edvinsson L, Goadsby PJ. Neuropeptides in headache. Eur J Neurol. 1998;5:329–41.CrossRef
12.
Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of man and the cat during activation of the trigeminovascular system. Ann Neurol. 1988;23:193–6.PubMedCrossRef
13.
Storer RJ, Akerman S, Goadsby PJ. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. British J of Pharm. 2004;142:1171–81.CrossRef
14.
Iversen HK, Olesen J, Tfelt-Hansen P. Intravenous nitroglycerin as an experimental headache model. Basic characteristics. Pain. 1989;38:17–24.PubMedCrossRef
15.
Afridi S, Kaube H, Goadsby PJ. Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain. 2004;110:675–80.PubMedCrossRef
16.
Juhasz G, Zsombok T, Modos EA, et al. NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain. 2003;106:461–70.PubMedCrossRef
17.
Juhasz G, Zsombok T, Jakab B, et al. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin-induced migraine attack. Cephalalgia. 2005;25:179–83.PubMedCrossRef
18.
Goadsby PJ, Knight YE, Hoskin KL. Stimulation of the greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat. Pain. 1997;73:23–8.PubMedCrossRef
19.
Hunter CR, Mayfield FH. Role of the upper cervical roots in the production of pain in the head. Am J Surg. 1949;78:743–9.PubMedCrossRef
20.
Kerr FWL. A mechanism to account for frontal headache in cases of posterior fossa tumors. J Neurosurg. 1961;18:605–9.PubMedCrossRef
21.
Piovesan EJ, Stani FD, Kowacs PA, Mulinari RA, Radunz VH, Utiumi M, et al. Massaging over the greater occipital nerve reduces the intensity of migraine attacks. Arq Neuropsiquiatr. 2007;65(3-A):599–604.PubMedCrossRef
22.
Le Bars D, Dickenson AH, Besson JM. Diffuse inhibitory controls (DNIC). Effects on dorsal horn convergent neurones in the rat. Pain. 1979;6:283–304.PubMedCrossRef
23.
Ellrich J, Treede RD. Characterization of blink reflex interneurons by activation of diffuse noxious inhibitory controls in man. Brain Res. 1998;803:161–8.PubMedCrossRef
24.
Kaube H, Hoskin KL, Goadsby PJ. Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat. Cephalalgia. 1992;12:133–6.PubMedCrossRef
25.
Goadsby PJ, Hoskin KL, Knight YE. Stimulation of greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat. Pain. 1997;73:23–8.PubMedCrossRef
26.
Herrero JF, Laird JM, Lopez-Garcia JA. Wind up of spinal cord neurons and pain sensation: much ado about something? Prog Neurobiol. 2000;61:169–203.PubMedCrossRef
27.
Magis D, Bruno MA, Fumal A, Gerardy PY, Hustinx R, Laureys S, et al. Central modulation in cluster headache patients treated with occipital nerve stimulation: an FDG-PET study. BMC Neurol. 2011;11:25.PubMedCrossRef
28.
Thimineur M, Ridder D. C2 area neuromodulation: a surgical treatment for fibromyalgia. Pain Med. 2007;8:639–46.PubMedCrossRef
29.
Headache Classification Committee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 2004;24 Suppl 1:9–160.
30.
Schulman EA, Lake AE, Goadsby PJ, et al. Defining refractory migraine and refractory chronic migraine: proposed criteria from the refractory headache special interest section of the American headache society. Headache. 2008;48:778–82.PubMedCrossRef
31.
Goadsby PJ, Schoenen J, Ferrari MD, et al. Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia. 2006;26:1168–70.PubMedCrossRef
32.
Jenkins B, Tepper SJ. Neurostimulation for primary headache disorders: part 2, review of central neurostimulators for primary headache, overall therapeutic efficacy, safety, cost, patient selection, and future research in headache neuromodulation. Headache. 2011;51:1408–18.PubMedCrossRef
33.
Schwedt TJ, Dodick DW, Trentman TL, et al. Response to occipital nerve block is not useful in predicting efficacy of occipital nerve stimulation. Cephalgia. 2007;27:271–4.CrossRef
34.
Lee PB, Huh BK, Pham NK. Long term follow up of peripheral nerve stimulation (PNS) for refractory chronic headache: A retrospective review of efficacy and safety of peripheral nerve stimulation [Abstract A204]. Presented at ASA annual meeting. Oct 13–16, 2012.
35.
Barolat G, Ketcik B, He J. Long-term outcome of spinal cord stimulation for chronic pain management. Neuromodulation. 1998;1:19–29.PubMedCrossRef
36.
Burchiel KJ, Anderson VC, Wilson BJ, Denison DB, Olson KA, Shatin D. Prognostic factors of spinal cord stimulation for chronic back and Leg pain. Neurosurgery. 1995;36:1101–10.PubMedCrossRef
37.
Trentman TL, Zimmerman RS. Occipital nerve stimulation: technical and surgical aspects of implantation. Headache. 2008;48:319–27.PubMedCrossRef
38.
Kapural L, Mekhail N, Hayek SM, Stanton-Hicks M, Malak O. Occipital nerve electrical stimulation via the midline approach and subcutaneous surgical leads for treatment of severe occipital neuralgia: a pilot study. Anesth Analg. 2005;101:171–4.PubMedCrossRef
39.
Trentman TL, Slavin KV, Freeman JA, Zimmerman RS. Occipital nerve stimulator placement via a retromastoid to infraclavicular approach: a technical report. Stereotact Funct Neurosurg. 2010;88:121–5.PubMedCrossRef
40.
Shin JH, Kim YC, Jang IK, Kim JH, Park SY, Lee SC. Occipital nerve stimulation in a patient with an intractable chronic headache – a case report. KJA. 2011;60:298–301.
41.
Oh MY, Ortega J, Bellotte JB, Whiting DM, Alo KM. Peripheral nerve stimulation for the treatment of occipital neuralgia and transformed migraine using a C1-2-3 subcutaneous paddle style electrode: a technical report. Neuromodulation. 2004;7:103–12.PubMedCrossRef
42.
Slavin KV, Colpan ME, Munawar N, Wess C, Nersesyan H. Trigeminal and occipital peripheral nerve stimulation for craniofacial pain: a single institution experience and review of the literature. Neurosurg Focus. 2006;21(E6):1–5.CrossRef
43.
Melvin Jr EA, Jordan FR, Weiner RL, Primm D. Using peripheral stimulation to reduce the pain of C2 mediated occipital headaches: a preliminary report. Pain Physician. 2007;10:453–60.PubMed
44.
Falowski S, Wang D, Sabesan A, Sharan A. Occipital nerve stimulator systems: review of complications and surgical techniques. Neuromodulation. 2010;13:121–5.PubMedCrossRef
45.
Schwedt TJ, Dodick DW, Trentman TL, Zimmerman RS. Occipital nerve stimulation for chronic headache –long term safety and efficacy. Cephalalgia. 2007;27:153–7.PubMedCrossRef
46.
Burher AH, Barnett AH, Barnett CF, Obray JB, Mauck WD. Introduction of infection control measures to reduce infection associated with implantable pain therapy devices. Pain Pract. 2007;7:279–84.CrossRef
47.
Antibiotic prophylaxis for surgery. Treatment guidelines. The Medical Letter. 2004,2(20):27–32.
48.
Antimicrobial prophylaxis in surgery. The Medical Letter. 2001; 43(W1116-1117B):92–8.
49.
Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. Am J Health Syst Pharm. 1999;56:1839–88.
50.
Waddell TK, Rotstein OD. Antimicrobial prophylaxi in surgery (clinical practice guidelines). Can Med Assoc J. 1994;151(7):925–31.
51.
Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the national surgical infection prevention project. Am J Surg. 2005;189:395–404.PubMedCrossRef
52.
53.
Weiner RL, Alo KM, Reed KL, Fuller ML. Subcutaneous neurostimulation for intractable C-2 mediated headaches. J Neurosurg. 2001;94:398A (Abstract).
54.
Popency CA, Alo KM. Peripheral neurostimulation for the treatment of chronic, disabling transformed migraine. Headache. 2003;43:369–75.CrossRef
55.
• Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2010;31:271–85. The data from this feasibility study suggest occipital nerve stimulation for medically intractable chronic migraine headache can be carried out safely and is worthy of further study for this indication. Moreover, study suggested that the response to occipital nerve block may not predict treatment outcomes of occipital nerve stimulation in primary headache.
56.
Reed KL, Black SB, Banta CJ, Will KR. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience. Cephalgia. 2010;30:260–71.
57.
Magis D, Allena M, Bolla M, Pasqua VD, Remacle JM, Schoenen J. Occipital nerve stimulation for drug resistant chronic cluster headache: a prospective pilot study. Lancet Neurol. 2007;6:314–21.PubMedCrossRef
58.
Magis D, Gerardy PY, Remacle JM, Schoenen J. Sustained effectiveness of occipital nerve stimulation in drug resistant chronic cluster headache. Headache. 2011;51:1191–201.PubMedCrossRef
59.
Burns B, Watkins L, Goadsby PJ. Treatment of intractable chronic cluster headache by occipital nerve stimulation: long term follow up of eight patients. Lancet. 2007;369:1099–106.PubMedCrossRef
60.
Amin S, Buvanendran A, Park KS, Kroin JS, Moric M. Peripheral nerve stimulator for the treatment of supraorbital neuralgia: a retrospective case series. Cephalalgia. 2008;28:355–9.PubMedCrossRef
61.
Dunteman E. Peripheral nerve stimulation for unremitting ophthalmic post herpetic neuralgia. Neuromodulation. 2002;5:32–7.PubMedCrossRef
Metadata
Title
Peripheral Nerve Stimulation for the Treatment of Primary Headache
Authors
Pyungbok Lee
Billy K. Huh
Publication date
01-03-2013
Publisher
Current Science Inc.
Published in
Current Pain and Headache Reports / Issue 3/2013
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-012-0319-2

Other articles of this Issue 3/2013

Current Pain and Headache Reports 3/2013 Go to the issue

Psychiatric Management of Pain (M Clark, Section Editor)

Temperament, Character, and Personality Disorders in Chronic Pain

Cancer Pain (DA Marcus, Section Editor)

Acupuncture for Cancer Pain and Related Symptoms

Psychiatric Management of Pain (M Clark, Section Editor)

Psychological Resilience, Pain Catastrophizing, and Positive Emotions: Perspectives on Comprehensive Modeling of Individual Pain Adaptation

Uncommon Headache Syndromes (J Ailani, Section Editor)

Headache and Vasculitis

Psychiatric Management of Pain (MR Clark, Section editor)

Disposition and Adjustment to Chronic Pain